MedPath

Effect of Different Timings of Protein Supplementation in Hemodialysis Patients

Not Applicable
Completed
Conditions
Protein Supplementation
Interventions
Dietary Supplement: oral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session)
Registration Number
NCT05953636
Lead Sponsor
Alexandria University
Brief Summary

The aim of this work is to study the effect of different timings of protein supplementation on variable outcomes in hemodialysis patients.

Detailed Description

Chronic kidney disease (CKD) is a prevalent chronic condition and the incidence of end-stage renal disease (ESRD) is expected to increase over the next few decades. In patients with CKD, especially in those with ESRD and undergoing maintenance dialysis therapy (MDT), a state of metabolic and nutritional derangements, more aptly called protein-energy wasting (PEW), caused by a combination of insufficient intake, uremic toxins, inflammation, and superimposed catabolism, plays a major role among the many risk factors that affect outcomes of CKD. PEW, showing a high prevalence (up to 50-75%) in patients with CKD stages 4-5, is closely associated with both increased morbidity/mortality risk and worsens quality of life.

Oral nutritional supplement (ONS) is a simple and effective way to supplement energy and protein to malnourished patients on the basis of regular diet. Therefore, if the protein of regular diet in dialysis patients are not enough, they should be supplemented with (ONS) when appropriate.

It is common for nephrologists to prescribe oral nutritional supplements (ONS), but the compliance to these at prescribed doses is relatively low. While directly administering ONS during hemodialysis (HD) ensures compliance and has been shown to improve nutritional status in these patients, the risks of intradialytic hypotension, inadequate dialysis, hygiene issues, and staff burden remain major deterrents for caregivers from formulating policies with regard to intradialytic meals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Adult hemodialysis patients (≥18 years of age).
  • Received dialysis for at least 6 months prior to study screening.
  • Receive hemodialysis at least 3 times per week .
Exclusion Criteria
  • Receiving nutritional supplementation prior to study commencing or within 1 month of commencement in the study .
  • Participants with an allergy to any ingredients in the nutritional supplements.
  • Significant edema and fluid overload.
  • Hepatic patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
pre-dialyticoral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session)40 patients will receive oral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session) for 8 weeks 1 hour before the start of the session (pre-dialytic).
intra-dialyticoral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session)40 patients will receive oral protein nutritional supplement (ONS) for 8 weeks 2 hours after the start of the session (intra-dialytic).
inter-dialyticoral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session)40 patients will receive oral protein nutritional supplement (ONS) for 8 weeks in non-dialysis days (inter-dialytic).
Primary Outcome Measures
NameTimeMethod
effect on dialysis adequacy6 weeks

Estimation of Kt/V change at 6 weeks from baseline

effect on nutritional status6 weeks

assessment of nutritional status change at 6 weeks from baseline using Subjective Global Assessment (SGA)

effect on blood pressure6 weeks

systolic and diastolic Blood pressure change at 6 weeks from baseline

Secondary Outcome Measures
NameTimeMethod
effect on BMI6 weeks

BMI assessment change at 6 weeks from baseline

effect on serum albumin6 weeks

• serum albumin change at 6 weeks from baseline

Trial Locations

Locations (1)

Faculty of Medicine, Aexandria University

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath